![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
A US-Based Cost-Effectiveness Analysis of Boceprevir-Based Regimens in Previously Untreated Adult Subjects with Chronic Hepatitis C Genotype 1
|
|
|
Reported by Jules Levin AASLD Nov 5-8 2011 SF
S.A. Ferrante1*, J. Chhatwal2, E. Elbasha1, E.J. Dasbach1, A.C. El Khoury1, F. Poordad3, J-P. Bronowicki4, C.A. Brass1
1Merck Sharp & Dohme Corp., Whitehouse Station, NJ, USA, 2University of Pittsburgh, Pittsburgh, PA, USA, 3Hepatology and Liver Transplantation, Cedars-Sinai Medical Center, Los Angeles, CA, USA, 4Department of Hepato-Gastroenterology, University Hospital of Nancy, Nancy, France
![AASLD1.gif](../images/111611/111611-5/AASLD1.gif)
![AASLD2.gif](../images/111611/111611-5/AASLD2.gif)
![AASLD3.gif](../images/111611/111611-5/AASLD3.gif)
![AASLD4.gif](../images/111611/111611-5/AASLD4.gif)
![AASLD5.gif](../images/111611/111611-5/AASLD5.gif)
![AASLD6.gif](../images/111611/111611-5/AASLD6.gif)
![AASLD7.gif](../images/111611/111611-5/AASLD7.gif)
![AASLD8.gif](../images/111611/111611-5/AASLD8.gif)
![AASLD9.gif](../images/111611/111611-5/AASLD9.gif)
![AASLD10.gif](../images/111611/111611-5/AASLD10.gif)
![AASLD11.gif](../images/111611/111611-5/AASLD11.gif)
![AASLD12.gif](../images/111611/111611-5/AASLD12.gif)
![AASLD13.gif](../images/111611/111611-5/AASLD13.gif)
![AASLD14.gif](../images/111611/111611-5/AASLD14.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|